Company registration number 07211442 (England and Wales)
VILCABAMBA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
VILCABAMBA LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 5
VILCABAMBA LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
4
3,503,740
3,503,740
Capital and reserves
Called up share capital
6
200
200
Profit and loss reserves
3,503,540
3,503,540
Total equity
3,503,740
3,503,740

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 11 May 2026 and are signed on its behalf by:
Mr M Gore
Mr D Spivack
Director
Director
Company registration number 07211442 (England and Wales)
VILCABAMBA LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 October 2023
200
3,503,540
3,503,740
Year ended 30 September 2024:
Profit and total comprehensive income
-
420,000
420,000
Dividends
3
-
(420,000)
(420,000)
Balance at 30 September 2024
200
3,503,540
3,503,740
Year ended 30 September 2025:
Profit and total comprehensive income
-
800,000
800,000
Dividends
3
-
(800,000)
(800,000)
Balance at 30 September 2025
200
3,503,540
3,503,740
VILCABAMBA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 3 -
1
Accounting policies
Company information

Vilcabamba Limited is a private company limited by shares incorporated in England and Wales. The registered office is Trinity Court, Church Street, Rickmansworth, WD3 1RT.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

VILCABAMBA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Impairment of financial assets

These financial statements for the year ended 30 September 2025 are the first financial statements of Vilcabamba Limited prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 October 2023. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
VILCABAMBA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 5 -
3
Dividends
2025
2024
£
£
Final paid
800,000
420,000
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
3,503,740
3,503,740
5
Subsidiaries

Details of the company's subsidiaries at 30 September 2025 are as follows:

Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
Alan Spivack Limited
England and Wales
Wholesale of pharmaceutical goods
Ordinary shares
100.00
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
200
200
200
200
7
Related party transactions

The company has taken advantage of the exemption available under FRS 102 from the requirement to make disclosures concerning transactions with fellow group companies

8
Directors' transactions

Dividends totalling £800,000 (2024 - £420,000) were paid in the year in respect of shares held by the company's directors.

9
Ultimate controlling party

The ultimate controlling party is shared equally between M Gore, D Spivack, V Lewis and J Tierney by virtue of shareholdings in the company.

2025-09-30 2024-10-01 false false false 13 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr M Gore Mr D Spivack 07211442 2024-10-01 2025-09-30 07211442 2025-09-30 07211442 2024-09-30 07211442 core:ShareCapital 2025-09-30 07211442 core:ShareCapital 2024-09-30 07211442 core:RetainedEarningsAccumulatedLosses 2025-09-30 07211442 core:RetainedEarningsAccumulatedLosses 2024-09-30 07211442 core:ShareCapital 2023-09-30 07211442 core:RetainedEarningsAccumulatedLosses 2023-09-30 07211442 core:ShareCapitalOrdinaryShareClass1 2025-09-30 07211442 core:ShareCapitalOrdinaryShareClass1 2024-09-30 07211442 bus:Director1 2024-10-01 2025-09-30 07211442 bus:Director2 2024-10-01 2025-09-30 07211442 core:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30 07211442 2023-10-01 2024-09-30 07211442 core:RetainedEarningsAccumulatedLosses 2024-10-01 2025-09-30 07211442 core:Subsidiary1 2024-10-01 2025-09-30 07211442 core:Subsidiary1 1 2024-10-01 2025-09-30 07211442 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 07211442 bus:OrdinaryShareClass1 2025-09-30 07211442 bus:OrdinaryShareClass1 2024-09-30 07211442 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 07211442 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 07211442 bus:FRS102 2024-10-01 2025-09-30 07211442 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 07211442 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP